Duration of Prednisolone for Sydenham Chorea
Prednisolone should be administered for 1 to 3 months depending on disease severity in Sydenham chorea, with the most common effective regimen being 2 mg/kg/day for 4 weeks followed by gradual tapering. 1
Evidence-Based Treatment Duration
The 2025 consensus guidelines for Sydenham chorea provide the most current and authoritative recommendations 1. These guidelines establish that:
- Mild disease (symptoms present without disability): Immunotherapy may not be required
- Moderate disease: Immunotherapy should be considered
- Severe disease: Immunotherapy should be strongly considered
When corticosteroids are indicated, treatment duration of 1-3 months is recommended based on disease severity 1. This recommendation stems from a meta-analysis showing that corticosteroid treatment is associated with faster chorea resolution and reduced relapse rates 2.
Specific Dosing Protocol
The most rigorously studied regimen comes from a randomized controlled trial that demonstrated:
- Initial dose: 2 mg/kg/day prednisolone
- Duration: 4 weeks at full dose
- Taper: Gradual discontinuation after the initial 4 weeks 3
This protocol resulted in significantly shorter chorea duration (mean 54.3 days) compared to placebo (mean 119.9 days), with improvement visible within 1 week of treatment 3.
Key Clinical Considerations
Duration matters for outcomes: The meta-analysis of 1,479 patients clearly demonstrates that patients receiving ≥1 month of corticosteroids had:
- Median chorea duration of 1.2 months versus 2.8 months without corticosteroids
- Significantly lower odds of relapsing disease (OR 0.10,95% CI 0.04-0.25) 2
Avoid underdosing: The FDA label confirms pediatric dosing ranges from 0.14-2 mg/kg/day, with the 2 mg/kg/day dose falling within established safe parameters 4. Weight gain is the primary side effect with short-course treatment 3.
Treatment Algorithm
- Assess severity using functional impact (mild/moderate/severe)
- For moderate-to-severe disease: Initiate prednisolone 2 mg/kg/day (maximum 60 mg/day)
- Continue full dose for 4 weeks while monitoring clinical response
- Taper gradually over subsequent weeks if improvement occurs
- Total treatment duration: 1-3 months based on severity and response
Important Caveats
The consensus guidelines acknowledge that recommendations are based on one small RCT, observational data, and meta-analysis—the quality of evidence is not strong 1. However, given the significant functional impairment from untreated chorea and the favorable safety profile of short-course corticosteroids, treatment is justified in moderate-to-severe cases.
Alternative first-line option: If corticosteroids are contraindicated, intravenous immunoglobulin should be used instead 1.
Combination therapy: Corticosteroids should be combined with penicillin prophylaxis and may be used alongside symptomatic agents like sodium valproate for movement control 1, 2.